Shares of Dr Pepper Snapple Group Inc. (NYSE:DPS) have been given a consensus rating of “Hold” by the nineteen brokerages that are presently covering the stock. Two analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $97.12.

DPS has been the topic of several recent analyst reports. Citigroup Inc. increased their price objective on shares of Dr Pepper Snapple Group from $97.00 to $102.00 and gave the company a “neutral” rating in a report on Thursday, July 28th. Zacks Investment Research downgraded shares of Dr Pepper Snapple Group from a “hold” rating to a “sell” rating in a research note on Wednesday, June 29th. BMO Capital Markets reissued a “market perform” rating on shares of Dr Pepper Snapple Group in a research note on Friday, July 15th. Goldman Sachs Group Inc. reissued a “sell” rating and issued a $95.00 price target (up from $89.00) on shares of Dr Pepper Snapple Group in a research note on Friday, July 15th. Finally, Credit Suisse Group AG started coverage on shares of Dr Pepper Snapple Group in a research note on Thursday, September 15th. They issued an “outperform” rating and a $108.00 price target on the stock.

In other news, insider David Thomas sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 12th. The shares were sold at an average price of $97.20, for a total value of $194,400.00. Following the completion of the transaction, the insider now owns 40,000 shares of the company’s stock, valued at $3,888,000. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Martin M. Ellen sold 15,462 shares of the firm’s stock in a transaction that occurred on Thursday, July 28th. The shares were sold at an average price of $96.63, for a total transaction of $1,494,093.06. Following the completion of the transaction, the insider now directly owns 5,462 shares of the company’s stock, valued at approximately $527,793.06. The disclosure for this sale can be found here. Company insiders own 0.62% of the company’s stock.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/dr-pepper-snapple-group-inc-nysedps-receives-average-recommendation-of-hold-from-analysts.html

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Nomura Asset Management Co. Ltd. raised its position in Dr Pepper Snapple Group by 5.6% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 35,784 shares of the company’s stock valued at $3,335,000 after buying an additional 1,900 shares during the last quarter. Norges Bank acquired a new position in Dr Pepper Snapple Group during the fourth quarter valued at approximately $136,394,000. Chevy Chase Trust Holdings Inc. raised its position in Dr Pepper Snapple Group by 1.8% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 159,660 shares of the company’s stock valued at $14,276,000 after buying an additional 2,799 shares during the last quarter. DnB Asset Management AS raised its position in Dr Pepper Snapple Group by 22.6% in the first quarter. DnB Asset Management AS now owns 18,447 shares of the company’s stock valued at $1,650,000 after buying an additional 3,400 shares during the last quarter. Finally, Glenmede Trust Co. NA raised its position in Dr Pepper Snapple Group by 6.0% in the first quarter. Glenmede Trust Co. NA now owns 1,050,859 shares of the company’s stock valued at $93,965,000 after buying an additional 59,638 shares during the last quarter. 92.41% of the stock is owned by institutional investors and hedge funds.

Shares of Dr Pepper Snapple Group (NYSE:DPS) traded down 0.15% during trading on Wednesday, reaching $90.65. 541,432 shares of the company traded hands. The stock has a market capitalization of $16.81 billion, a PE ratio of 20.76 and a beta of 0.32. Dr Pepper Snapple Group has a 52 week low of $76.78 and a 52 week high of $98.80. The firm has a 50 day moving average of $94.00 and a 200 day moving average of $92.99.

Dr Pepper Snapple Group (NYSE:DPS) last posted its quarterly earnings data on Wednesday, July 27th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.05. The business had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.68 billion. Dr Pepper Snapple Group had a net margin of 13.04% and a return on equity of 37.43%. The company’s revenue was up 2.4% compared to the same quarter last year. During the same period last year, the firm posted $1.13 earnings per share. On average, equities analysts predict that Dr Pepper Snapple Group will post $4.37 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 5th. Shareholders of record on Tuesday, September 13th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.34%. The ex-dividend date of this dividend is Friday, September 9th. Dr Pepper Snapple Group’s dividend payout ratio is presently 48.51%.

About Dr Pepper Snapple Group

Dr Pepper Snapple Group, Inc is an owner, manufacturer and distributor of non-alcoholic beverages in the United States, Canada and Mexico. The Company’s products consist of flavored (non-cola) carbonated soft drinks (CSDs) and non-carbonated beverages (NCBs), including ready-to-drink teas, juices, juice drinks, water and mixers.

5 Day Chart for NYSE:DPS

Receive News & Ratings for Dr Pepper Snapple Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr Pepper Snapple Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.